Patent · US Active

Bispecific antibodies that bind to CD38 and CD3

US9822186B2 · kind B2 · utility

6Cited by
118References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 30, 2015
Grant dateNov 21, 2017
Priority date—
Expiry dateMar 30, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention provides novel heterodimeric proteins including heterodimeric antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.